No abstract available
MeSH terms
-
Age Factors
-
Aged
-
Aged, 80 and over
-
Biomarkers
-
Combined Modality Therapy
-
Disease Management
-
Humans
-
Immunoglobulin Light-chain Amyloidosis / diagnosis*
-
Immunoglobulin Light-chain Amyloidosis / etiology
-
Immunoglobulin Light-chain Amyloidosis / mortality
-
Immunoglobulin Light-chain Amyloidosis / therapy*
-
Prognosis
-
Treatment Outcome